التفاصيل البيبلوغرافية
| العنوان: |
Cross-validating the Clinical Assessment of Attention Deficit–Adult symptom validity scales for assessment of attention deficit/hyperactivity disorder in adults. |
| المؤلفون: |
Finley, John-Christopher A., Cerny, Brian M., Brooks, Julia M., Obolsky, Maximillian A., Haneda, Aya, Ovsiew, Gabriel P., Ulrich, Devin M., Resch, Zachary J., Soble, Jason R. |
| المصدر: |
Journal of Clinical & Experimental Neuropsychology; Mar2024, Vol. 46 Issue 2, p111-123, 13p |
| مصطلحات موضوعية: |
ATTENTION-deficit hyperactivity disorder, HYPERACTIVITY, ADULTS, SYMPTOMS, ATTENTION |
| مستخلص: |
The Clinical Assessment of Attention Deficit-Adult is among the few questionnaires that offer validity indicators (i.e., Negative Impression [NI], Infrequency [IF], and Positive Impression [PI]) for classifying underreporting and overreporting of attention-deficit/hyperactivity disorder (ADHD) symptoms. This is the first study to cross-validate the NI, IF, and PI scales in a sample of adults with suspected or known ADHD. Univariate and multivariate analyses were conducted to examine the independent and combined value of the NI, IF, and PI scores in predicting invalid symptom reporting and neurocognitive performance in a sample of 543 adults undergoing ADHD evaluation. The NI scale demonstrated better classification accuracy than the IF scale in discriminating patients with and without valid scores on measures of overreporting. Only NI scores significantly predicted validity status when used in combination with IF scores. Optimal cut-scores for the NI (≤51; 30% sensitivity / 90% specificity) and IF (≥4; 18% sensitivity / 90% specificity) scales were consistent with those reported in the original manual; however, these indicators poorly discriminated patients with invalid and valid neurocognitive performance. The PI scale demonstrated acceptable classification accuracy in discriminating patients with invalid and valid scores on measures of underreporting, albeit with an optimal cut-score (≥27; 36% sensitivity / 90% specificity) lower than that described in the manual. Findings provide preliminary evidence of construct validity for these scales as embedded validity indicators of symptom overreporting and underreporting. However, these scales should not be used to guide clinical judgment regarding the validity of neurocognitive test performance. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical & Experimental Neuropsychology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
PDF full text from Publisher 
Full Text Finder